Corvus Pharmaceuticals Announces First Quarter 2016 Financial Results

Go back to Corvus Pharmaceuticals Announces First Quarter 2016 Financial Results
(NASDAQ: CRVS) Delayed: 14.54 +0.21 (1.47%)
Previous Close $14.33    52 Week High $17.77 
Open $14.65    52 Week Low $9.63 
Day High $14.65    P/E N/A 
Day Low $14.46    EPS $0.00 
Volume 39,435